Litcius/Paper detail

LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial

M. Allaf, S.E. Kim, L.C. Harshman, David F. McDermott, V.A. Master, S. Signoretti, S. Cole, H. Moon, N. Adra, E.A. Singer, J. Gills, Toni K. Choueiri, B. Leibovich, M.D. Michaelson, B. shuch, Primo N. Lara, D.Y.C. Heng, A. Kapoor, M.A. Carducci, N.B. Haas

2022Annals of Oncology74 citationsDOI

Topics & Concepts

MedicineNivolumabRenal cell carcinomaPerioperativeRandomized controlled trialOncologyInternal medicineNephrectomyClinical trialKidney cancerCancerSurgeryKidneyImmunotherapyRenal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers